ATE234356T1 - Menschliches zelladhäsionsmolekülaamp-1 und dessen verwendungen - Google Patents

Menschliches zelladhäsionsmolekülaamp-1 und dessen verwendungen

Info

Publication number
ATE234356T1
ATE234356T1 AT94921368T AT94921368T ATE234356T1 AT E234356 T1 ATE234356 T1 AT E234356T1 AT 94921368 T AT94921368 T AT 94921368T AT 94921368 T AT94921368 T AT 94921368T AT E234356 T1 ATE234356 T1 AT E234356T1
Authority
AT
Austria
Prior art keywords
aamp
fragments
present
cell
dna segment
Prior art date
Application number
AT94921368T
Other languages
English (en)
Inventor
Marie E Beckner
Henry C Krutzsch
Lance A Liotta
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE234356T1 publication Critical patent/ATE234356T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
AT94921368T 1993-06-25 1994-06-23 Menschliches zelladhäsionsmolekülaamp-1 und dessen verwendungen ATE234356T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/083,945 US6274134B1 (en) 1992-01-29 1993-06-25 Human cell adhesion protein AAMP-1 and uses thereof
PCT/US1994/007107 WO1995000643A2 (en) 1993-06-25 1994-06-23 Human cell adhesion protein aamp-1 and uses thereof

Publications (1)

Publication Number Publication Date
ATE234356T1 true ATE234356T1 (de) 2003-03-15

Family

ID=22181676

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94921368T ATE234356T1 (de) 1993-06-25 1994-06-23 Menschliches zelladhäsionsmolekülaamp-1 und dessen verwendungen

Country Status (8)

Country Link
US (1) US6274134B1 (de)
EP (1) EP0705339B1 (de)
JP (1) JP3715313B2 (de)
AT (1) ATE234356T1 (de)
AU (1) AU684806B2 (de)
CA (1) CA2165559A1 (de)
DE (1) DE69432255D1 (de)
WO (1) WO1995000643A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0624193A1 (de) * 1992-01-29 1994-11-17 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES AAMP-1, ein Protein mit HIV-1 Env und Nef Proteinen lokalen Homologien

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126433A (en) 1986-08-21 1992-06-30 The Trustees Of Columbia University In The City Of New York Soluble forms of the t cell surface protein cd4
US5110906A (en) 1986-08-21 1992-05-05 The Trustees Of Columbia University In The City Of New York Derivatives of soluble T-4
US4870160A (en) 1987-08-19 1989-09-26 Regents Of The University Of Minnesota Polypeptides with laminin activity
US4839464A (en) * 1987-08-25 1989-06-13 Regents Of The University Of Minnesota Polypeptides with fibronectin activity
US5019646A (en) 1987-08-25 1991-05-28 Regents Of The University Of Minnesota Polypeptides with fibronectin activity
US5120828A (en) 1989-05-08 1992-06-09 Regents Of The University Of Minnesota Synthetic polypeptide with laminin activity
WO1991009054A1 (en) 1989-12-14 1991-06-27 Regents Of The University Of Minnesota Type iv collagen polypeptide
US5152784A (en) 1989-12-14 1992-10-06 Regents Of The University Of Minnesota Prosthetic devices coated with a polypeptide with type IV collagen activity
US5081031A (en) 1989-12-14 1992-01-14 Regents Of The University Of Minnesota Synthetic polypeptide with type iv collagen activity
GB9101183D0 (en) 1991-01-18 1991-02-27 Univ London Depot formulations
EP0624193A1 (de) 1992-01-29 1994-11-17 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES AAMP-1, ein Protein mit HIV-1 Env und Nef Proteinen lokalen Homologien
US7827043B2 (en) * 2001-02-15 2010-11-02 Tahan A Christian Method using a global server for providing patient medical histories to assist in the delivery of emergency medical services

Also Published As

Publication number Publication date
JPH08511941A (ja) 1996-12-17
US6274134B1 (en) 2001-08-14
EP0705339B1 (de) 2003-03-12
JP3715313B2 (ja) 2005-11-09
CA2165559A1 (en) 1995-01-05
AU7212594A (en) 1995-01-17
EP0705339A1 (de) 1996-04-10
DE69432255D1 (de) 2003-04-17
WO1995000643A3 (en) 1995-03-16
AU684806B2 (en) 1998-01-08
WO1995000643A2 (en) 1995-01-05

Similar Documents

Publication Publication Date Title
Matsushima et al. Production of interleukin 1 activity by normal human peripheral blood B lymphocytes.
Hollenberg et al. Human urogastrone and mouse epidermal growth factor share a common receptor site in cultured human fibroblasts
NO963371L (no) Hematopoietisk protein samt materialer og fremgangsmåter for fremstilling av det
ATE201416T1 (de) Varianten von adhäsionsmoleküle für blutplättchen
PT93910A (pt) Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula
CA2038398A1 (en) Dna encoding a growth factor specific for epithelial cells
DE10075010I1 (de) Fusionsproteine mit immunglobulinanteilen ihre Herstellung und Verwendung
DE69124857D1 (de) DNS, die ein menschliches, gefässverengendes Peptid kodiert, und dessen Verwendung
EP0837934A4 (de) Menschlicher wachstumsfaktor, spezifisch für vaskuläre endothelzellen
IL123189A0 (en) Colon cell and colon cancer cell associated nucleic acid molecules protein and peptides
SE9500023D0 (sv) Method of detecting cancer
AU1860395A (en) Novel human beta 2 integrin alpha subunit
WO1997008314A3 (en) Telomere repeat binding factor and diagnostic and therapeutic use thereof
EP0114887B1 (de) Polypeptide
ATE234356T1 (de) Menschliches zelladhäsionsmolekülaamp-1 und dessen verwendungen
DE19781038T1 (de) Keratinozytenwachstumsfaktor-2-Produkte
Kuroki et al. Coproduction of carcinoembryonic antigen and nonspecific cross-reacting antigen by a continuous cell line from a human pancreatic tumor
DK0629238T3 (da) Autotaxin:Motilitetsstimulerende protein, som er nyttigt til cancerdiagnose og terapi
Osborn et al. Amino terminal peptides of RNA phage proteins synthesized in the cell free system
ATE302214T1 (de) Enamel-matrix bezogene polypeptide
DE59712771D1 (de) Nebenhoden-spezifisches Rezeptorprotein und dessen Verwendung
DE69634994D1 (de) Bindegewebe-wachstumsfaktor 3.
Bankowski et al. Human procollagen: I. An anionic tropocollagen precursor from skin fibroblasts in culture
Rocco et al. Conformational state of circulating human plasma fibronectin
EP0322084A3 (de) Tumorzellenhemmender Faktor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties